CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
10.1038/nature07179
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I. F., Silver, S. J., Guney, I., Freed, E., Ligon, A. H., Vena, N., Ogino, S., Chheda, M. G., Tamayo, P., Finn, S., Shrestha, Y., Boehm, J. S., Jain, S., Bojarski, E., Mermel, C., Barretina, J., … Hahn, W. C. (2008). CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature, 455(7212), 547–551.

Authors 28
  1. Ron Firestein (first)
  2. Adam J. Bass (additional)
  3. So Young Kim (additional)
  4. Ian F. Dunn (additional)
  5. Serena J. Silver (additional)
  6. Isil Guney (additional)
  7. Ellen Freed (additional)
  8. Azra H. Ligon (additional)
  9. Natalie Vena (additional)
  10. Shuji Ogino (additional)
  11. Milan G. Chheda (additional)
  12. Pablo Tamayo (additional)
  13. Stephen Finn (additional)
  14. Yashaswi Shrestha (additional)
  15. Jesse S. Boehm (additional)
  16. Supriya Jain (additional)
  17. Emeric Bojarski (additional)
  18. Craig Mermel (additional)
  19. Jordi Barretina (additional)
  20. Jennifer A. Chan (additional)
  21. Jose Baselga (additional)
  22. Josep Tabernero (additional)
  23. David E. Root (additional)
  24. Charles S. Fuchs (additional)
  25. Massimo Loda (additional)
  26. Ramesh A. Shivdasani (additional)
  27. Matthew Meyerson (additional)
  28. William C. Hahn (additional)
References 33 Referenced 584
  1. Bienz, M. & Clevers, H. Linking colorectal cancer to Wnt signaling. Cell 103, 311–320 (2000) (10.1016/S0092-8674(00)00122-7) / Cell by M Bienz (2000)
  2. Camp, R. L., Chung, G. G. & Rimm, D. L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Med. 8, 1323–1327 (2002) (10.1038/nm791) / Nature Med. by RL Camp (2002)
  3. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525–532 (1988) (10.1056/NEJM198809013190901) / N. Engl. J. Med. by B Vogelstein (1988)
  4. Conaway, R. C., Sato, S., Tomomori-Sato, C., Yao, T. & Conaway, J. W. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem. Sci. 30, 250–255 (2005) (10.1016/j.tibs.2005.03.002) / Trends Biochem. Sci. by RC Conaway (2005)
  5. Smith, G. et al. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA 99, 9433–9438 (2002) (10.1073/pnas.122612899) / Proc. Natl Acad. Sci. USA by G Smith (2002)
  6. van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250 (2002) (10.1016/S0092-8674(02)01014-0) / Cell by M van de Wetering (2002)
  7. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283–1298 (2006) (10.1016/j.cell.2006.01.040) / Cell by J Moffat (2006)
  8. Korinek, V. et al. Constitutive transcriptional activation by a β-catenin–Tcf complex in APC-/- colon carcinoma. Science 275, 1784–1787 (1997) (10.1126/science.275.5307.1784) / Science by V Korinek (1997)
  9. Davidson, G. et al. Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438, 867–872 (2005) (10.1038/nature04170) / Nature by G Davidson (2005)
  10. Hino, S., Michiue, T., Asashima, M. & Kikuchi, A. Casein kinase Iε enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of β-catenin. J. Biol. Chem. 278, 14066–14073 (2003) (10.1074/jbc.M213265200) / J. Biol. Chem. by S Hino (2003)
  11. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007–20012 (2007) (10.1073/pnas.0710052104) / Proc. Natl Acad. Sci. USA by R Beroukhim (2007)
  12. Weir, B. A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893–898 (2007) (10.1038/nature06358) / Nature by BA Weir (2007)
  13. Martin, E. S. et al. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res. 67, 10736–10743 (2007) (10.1158/0008-5472.CAN-07-2742) / Cancer Res. by ES Martin (2007)
  14. Tsafrir, D. et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 66, 2129–2137 (2006) (10.1158/0008-5472.CAN-05-2569) / Cancer Res. by D Tsafrir (2006)
  15. Morris E. J. et al. E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8. Nature 10.1038/nature07310 (this issue).
  16. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005) (10.1073/pnas.0506580102) / Proc. Natl Acad. Sci. USA by A Subramanian (2005)
  17. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117–122 (2005) (10.1038/nature03664) / Nature by LA Garraway (2005)
  18. Gold, M. O. & Rice, A. P. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression. Nucleic Acids Res. 26, 3784–3788 (1998) (10.1093/nar/26.16.3784) / Nucleic Acids Res. by MO Gold (1998)
  19. Ilyas, M., Tomlinson, I. P., Rowan, A., Pignatelli, M. & Bodmer, W. F. β-Catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA 94, 10330–10334 (1997) (10.1073/pnas.94.19.10330) / Proc. Natl Acad. Sci. USA by M Ilyas (1997)
  20. Sparks, A. B., Morin, P. J., Vogelstein, B. & Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130–1134 (1998) / Cancer Res. by AB Sparks (1998)
  21. Rowan, A. J. et al. APC mutations in sporadic colorectal tumors: A mutational “hotspot” and interdependence of the “two hits”. Proc. Natl Acad. Sci. USA 97, 3352–3357 (2000) (10.1073/pnas.97.7.3352) / Proc. Natl Acad. Sci. USA by AJ Rowan (2000)
  22. Tassan, J. P., Jaquenoud, M., Leopold, P., Schultz, S. J. & Nigg, E. A. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc. Natl Acad. Sci. USA 92, 8871–8875 (1995) (10.1073/pnas.92.19.8871) / Proc. Natl Acad. Sci. USA by JP Tassan (1995)
  23. Sansom, O. J. et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676–679 (2007) (10.1038/nature05674) / Nature by OJ Sansom (2007)
  24. Murakami, T. et al. Constitutive activation of Wnt/β-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem. Biophys. Res. Commun. 288, 8–15 (2001) (10.1006/bbrc.2001.5719) / Biochem. Biophys. Res. Commun. by T Murakami (2001)
  25. He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509–1512 (1998) (10.1126/science.281.5382.1509) / Science by TC He (1998)
  26. Fryer, C. J., White, J. B. & Jones, K. A. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 16, 509–520 (2004) (10.1016/j.molcel.2004.10.014) / Mol. Cell by CJ Fryer (2004)
  27. Yook, J. I. et al. A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells. Nature Cell Biol. 8, 1398–1406 (2006) (10.1038/ncb1508) / Nature Cell Biol. by JI Yook (2006)
  28. Chiang, M. Y. et al. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol. Cell. Biol. 26, 6261–6271 (2006) (10.1128/MCB.02478-05) / Mol. Cell. Biol. by MY Chiang (2006)
  29. Kolligs, F. T., Hu, G., Dang, C. V. & Fearon, E. R. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696–5706 (1999) (10.1128/MCB.19.8.5696) / Mol. Cell. Biol. by FT Kolligs (1999)
  30. Boehm, J. S. et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129, 1065–1079 (2007) (10.1016/j.cell.2007.03.052) / Cell by JS Boehm (2007)
  31. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007–20012 (2007) (10.1073/pnas.0710052104) / Proc. Natl Acad. Sci. USA by R Beroukhim (2007)
  32. Damalas, A. et al. Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20, 4912–4922 (2001) (10.1093/emboj/20.17.4912) / EMBO J. by A Damalas (2001)
  33. Weir, B. A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893–898 (2007) (10.1038/nature06358) / Nature by BA Weir (2007)
Dates
Type When
Created 16 years, 11 months ago (Sept. 16, 2008, 6:26 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 2:17 p.m.)
Indexed 15 minutes ago (Aug. 25, 2025, 10:04 p.m.)
Issued 16 years, 11 months ago (Sept. 1, 2008)
Published 16 years, 11 months ago (Sept. 1, 2008)
Published Online 16 years, 11 months ago (Sept. 14, 2008)
Published Print 16 years, 11 months ago (Sept. 1, 2008)
Funders 0

None

@article{Firestein_2008, title={CDK8 is a colorectal cancer oncogene that regulates β-catenin activity}, volume={455}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature07179}, DOI={10.1038/nature07179}, number={7212}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Firestein, Ron and Bass, Adam J. and Kim, So Young and Dunn, Ian F. and Silver, Serena J. and Guney, Isil and Freed, Ellen and Ligon, Azra H. and Vena, Natalie and Ogino, Shuji and Chheda, Milan G. and Tamayo, Pablo and Finn, Stephen and Shrestha, Yashaswi and Boehm, Jesse S. and Jain, Supriya and Bojarski, Emeric and Mermel, Craig and Barretina, Jordi and Chan, Jennifer A. and Baselga, Jose and Tabernero, Josep and Root, David E. and Fuchs, Charles S. and Loda, Massimo and Shivdasani, Ramesh A. and Meyerson, Matthew and Hahn, William C.}, year={2008}, month=sep, pages={547–551} }